| Document |
Document Title |
|
WO/2009/086209A2 |
Synthesis of platinum(II) di(2-pyrazolyl)benzene chloride and analogs includes forming a 1,3-di-substituted benzene including two aromatic five-membered heterocycles, and reacting the 1,3-di-substituted benzene with an acidic platinum-co...
|
|
WO/2009/083899A2 |
The present invention relates to a process for the preparation of the compound of formula (7) which process comprises the hydrogenation of the compound of formula (4) using bis[chloro-1,5-cyclooctadiene-iridium], (S)-i -dicyclohexylphosp...
|
|
WO/2009/080853A1 |
The invention relates to compounds having formula (I), wherein: the broken line represents a single or double bond; X is N, O, S, or -(CH2)n-; n is an integer between 1 and 3; R1 is a radical selected independently from among (C1-C4) alk...
|
|
WO/2009/080216A1 |
The present invention relates to monohydroindacenyl complexes as active catalytic components in the copolymerization of ethylene. The complexes are suitable for direct preparation of ethylene copolymers having a narrow molecular distribu...
|
|
WO/2009/077115A1 |
The present invention relates to a process for preparing transition metal compounds, in particular ansa-bisindenyl-metallocenes having nitrogen, phosphor, sulfur or oxygen comprising substituents, the corresponding transition metal compo...
|
|
WO/2009/075821A1 |
The present invention is directed to a method of making a ligand which can be used to form an ansa-metallocene. Further, the present invention is directed to a method of making the ansa-metallocene. In both methods the process steps empl...
|
|
WO/2009/070847A1 |
The present invention relates to a transition metal complex represented by Formula (I) or salts thereof, or to a ligand represented by Formula (H) or salts thereof, wherein X represents a transition metal, preferably Pt, and methods for ...
|
|
WO/2009/072505A1 |
Disclosed is a method for producing an organic alkali metal compound with high yield. Also disclosed is a method for producing an organic transition metal compound using the organic alkali metal compound. Specifically disclosed is a meth...
|
|
WO/2009/068000A2 |
The invention relates to cyclopentadienylphosphazene complexes (CpPN complexes) of metals of the III. and VI. group and of the lanthanoids except for lutetium. The complexes of the invention are isolobal and isoelectric with respect to t...
|
|
WO/2009/065784A1 |
Compounds of the formula (I), in the form of mixtures comprising predominantly one diastereomer or in the form of pure diastereomers, Z1-Q-P*R0R1 (I) in which Z1 is a C-bonded, secondary phosphine group -P(R)2; in which R is in each case...
|
|
WO/2009/066689A1 |
It relates to a metallocene compound useful as an olefin polymerization catalyst or catalyst component, and an olefin polymerization method using an olefin polymerization catalyst containing the metallocene compound. More particularly, i...
|
|
WO/2009/061991A1 |
Disclosed is a method for preparing a compound of Formula 1 comprising contacting a compound of Formula 2 with at least one alkali metal cyanide of Formula 3 and a compound of Formula 4 wherein R1 is NHR3 or OR4; R2 is CH3 or Cl; R3 is H...
|
|
WO/2009/050037A1 |
A metallocene compound of formula (I) Wherein M is an atom of a transition metal; X, is a hydrogen atom, a halogen atom, or a hydrocarbon group optionally containing heteroatoms R1 and R2, equal to or different from each other, are C1-C4...
|
|
WO/2009/045300A2 |
The present techniques relate to catalyst compositions, methods, and polymers encompassing a Group 4 metallocene compound comprising bridged 5-cyclopentadienyl-type ligands, typically in combination with a cocatalyst, and a activator. Th...
|
|
WO/2009/043300A1 |
A 1,2-disubstituted ruthenocene chiral ligand of formula(1)or(2)comprises central chirality and plane chirality which have S structure or R structure and its preparation. Substituent R of formula(1)or(2)represents linear alkyl or branch-...
|
|
WO/2009/045301A2 |
The present techniques relate to catalyst compositions, methods, and polymers encompassing a Group 4 metallocene compound comprising bridging 5-cyclopentadienyl-type ligands, typically in combination with a cocatalyst, and a activator. T...
|
|
WO/2009/038041A1 |
Disclosed is a transition metal ion complex represented by the following general formula (1). (In the formula, M represents a group 4 element of the periodic table; A represents a group 14 element of the periodic table; D represents a gr...
|
|
WO/2009/037277A1 |
The invention relates to the use of compounds having at least one 2- (1-H-tetrazol- 5-yl) -pyridine pattern of the following formula (I), as lanthanide ligands, and more particularly as organic chromophores for complexing these elements....
|
|
WO/2009/027075A2 |
A complex comprising a ligand of formula (I), wherein each R1, which may be the same or different, is hydrogen, an optionally substituted C1-20 hydrocarbyl group, N(R5)2, silyl, siloxy; an optionally substituted heteroaryl group, an opti...
|
|
WO/2009/024675A2 |
Novel group 4 organometallic compounds, supported on anions by means of at least one covalent metal-oxygen bond, are obtained by reaction of at least one borate or aluminate comprising at least one hydroxy group with at least one group 4...
|
|
WO/2009/013724A2 |
The present invention relates to new medicaments, pharmaceutical compositions and methods of treatment of cancer. Disclosed are trimetallic clusters for use as a medicament, in particular in the treatment of cancer including metastasis. ...
|
|
WO/2009/007755A1 |
The present invention provides a method for binding gaseous molecules, the method comprising contacting gases comprising the gaseous molecules with trivaient metal complexes. Typically, the gaseous motecuies comprise polar molecules of g...
|
|
WO/2008/138540A1 |
The invention relates to ruthenium complexes with a chiral ferrocenyldiphosphine ligand, wherein the ruthenium has the oxidation state (+II) and the chiral ferrocenyldiphosphine ligand has bidentate P-P coordination to the ruthenium. The...
|
|
WO/2008/130121A1 |
Disclosed are a novel cyclotriphosphazene-platinum(II) complex conjugate anticancer agent, showing high selectivity to tumor tissues due to the enhanced permeability and retention effect in tumor tissues and a preparation method thereof.
|
|
WO/2008/119431A1 |
Multinuclear catalyst complex comprising two or more active metal centres and at least one phenoxyimine compound and at least one substituted cyclopentadienyl, indenyl or fluorenyl derivative, each phenoxyimine compound being bonded to a...
|
|
WO/2008/114790A1 |
A transition metal complex represented by the formula (1): (1)(wherein A represents the atom of a Group 16 element of the periodic table; B1 represents the atom of a Group 14 element of the periodic table; M1 represents the atom of a Gro...
|
|
WO/2008/110774A2 |
The present invention relates to per-substituted pentalene compounds, including permethylpentalene and precursors thereof. In particular, the invention provides substituted pentalene compounds and methods of preparing substituted pentale...
|
|
WO/2008/104382A2 |
Process for preparing bridged, stereorigid, stereomerically pure dialkoxide metallocenes, diaryl oxide metallocenes and preferably diphenoxide metallocenes of the general formula Q(Cp)(Cp')M(OR3)2 in which Cp = a cyclopentadienyl, an ind...
|
|
WO/2008/101868A1 |
Abstract Compounds of the formula (I) in the form of racemates, enantiomerically pure diastereomers or a mixture of diastereomers, where the radicals R1 are identical or different and are each C1-C4-alkyl; m is 0 or an integer from 1 to ...
|
|
WO/2008/094222A2 |
This invention provides a novel class of substituted macrocyclic porphyrin compounds. The compounds are useful as peroxynitrite decomposition catalysts. Pharmaceutical compositions, and methods of making and using the compounds, or a pha...
|
|
WO/2008/093668A1 |
Disclosed is a novel chiral iridium aqua complex which can be used for an asymmetric transfer hydrogenation reaction of a carbonyl compound. Specifically disclosed is a chiral iridium aqua complex represented by the following formula (1)...
|
|
WO/2008/090526A1 |
The present invention relates to novel organometallic compounds for use as a medicine, in particular in photodynamic therapy against various diseases, such as cancer or inflammatoryand/or immune disorders. The compounds comprise a centra...
|
|
WO/2008/088563A2 |
Precursor compositions useful for atomic layer deposition (ALD) and chemical vapor deposition (CVD) of strontium ruthenium oxide (SrRuO3) thin films, e.g., in the manufacture of microelectronic devices, as well as processes of making and...
|
|
WO/2008/078092A1 |
The present invention relates to detectors for detecting fluorine containing compounds and/or cyanide containing compounds, including hydrogen fluoride (HF) or HCN gas, hydrofluoric acid in solution, selected chemical warfare agents, sel...
|
|
WO/2008/065448A1 |
Novel bidentate ligands of general formula (I) are described Formula (I): R represents a hydrocarbyl aromatic structure. The substituent(s) Yx on the aromatic structure has a total X=1-n ΣtYx of atoms other than hydrogen such that x-1-n...
|
|
WO/2008/059068A2 |
Disclosed is a medicament containing a compound of formula (Ia) or (Ib), wherein Z is selected from among a group comprising a covalent bond, at least one at least bivalent heteroatom, a saturated, unsaturated, branched, linear and/or cy...
|
|
WO/2008/055942A1 |
[(RcRc)-, (SFc,SFc)-, (SP,SP)-1,1'-Bis(2-sec-aminoalkyl)-1-ferrocenyl]phosphino-fe
rrocene or the enantiomer [(Sc,Sc)-, (RFc,RFc)-, (RP,RP)-1,1'-bis (2-sec-aminoalkyl)-1-ferrocenyl]phosphinoferrocene are enriched by heating a mixture of ...
|
|
WO/2008/049790A1 |
Compound of the formula (Ia), or of the formula (Ib). These new precursors are useful for pure metal, metallic oxide, oxynitride, nitride and/or silicide film deposition to make electrodes and/or high k layers, and/or copper diffusion ba...
|
|
WO/2008/047173A1 |
The invention relates to a catalyst for the heterogeneous phase polymerisation of conjugated dienes and olefins, comprising a pre-catalyst consisting of a mixture of metallocene hydride-aluminohydride compounds: (CpRx)Ty(CpR'z)MHAIH4 (I)...
|
|
WO/2008/039916A1 |
This invention relates to organometallic compounds represented by the formula (L1)yM(L2)z-y wherein M is a Group 5 metal or a Group 6 metal, L1 is a substituted or unsubstituted anionic 6 electron donor ligand, L2 is the same or differen...
|
|
WO/2008/037608A1 |
The present invention discloses efficient methods for preparing substituted cyclopentadienyl-fluorenyl catalyst components having a diphenyl bridge.
|
|
WO/2008/034468A1 |
The invention concerns the use of the ruthenium containing precursor having the formula (Rn-chd) Ru(CO)3, wherein: - (Rn-chd) represents a cyclohexadiene (chd) ligand substituted with n substituents R, any R being in any position on the ...
|
|
WO/2008/034809A1 |
Compounds of the formulae (I) and (II), or a mixture of these enantiomers, where R'1 is C1-C4-alkyl and n is 0, 1 or 2; R1 is C1-C8-alkyl, C2-C8-alken-1-yl, -CH2-OR or - CH2-NR5R6; the two radicals R2 are identical or different and are e...
|
|
WO/2008/036882A1 |
A non-metallocene organometallic complex comprising a tridentate ligand and a metal bonded to a tridentate ligand, wherein two substituted aryl groups in the tridentate ligand are connected to a cyclic group at the ortho position via sem...
|
|
WO/2008/017855A1 |
The present invention relates to osmium compounds of formula [I), their preparation and use in methods of treatment, particularly for cancer treatment.
|
|
WO2007017522A9 |
Compounds of the formula (I) in the form of racemates, mixtures of stereoisomers or optically pure stereoisomers, formula (I), where X1 and X2 are each, independently of one another, a secondary phosphino group; R1 is a halogen atom or a...
|
|
WO/2008/004628A1 |
Disclosed is a rare earth metal complex represented by the following formula (1). (1) (In the formula, A represents a group 14 element of the periodic table; Cp represent a substituted or unsubstituted group having a cyclopentadienyl typ...
|
|
WO/2008/000815A1 |
Compounds of the formulae I and Ia in the form of mixtures of diastereomers or pure diastereomers, (I), (Ia), where R1 is a hydrogen atom or C1-C4-alkyl and R'1 is C1-C4-alkyl; X1 and X2 are each, independently of one another, a sec-phos...
|
|
WO/2007/140717A1 |
The invention affords C2-symmetrical ruthenocene diphosphine ligands with surface chirality and their manufacture. The present invention uses (S)- (S)- 1, 1' - 2 (biphenyl phosphino)-2, 2'-2[(S)- 4- isopropyl oxazolinyl] ruthenocene as r...
|
|
WO/2007/139440A2 |
The present invention discloses a class of supported metallocene catalyst systems that can be activated without aluminoxane or perfluorophenylborate.
|
